会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Systems and methods for providing arrhythmia therapy in MRI environments
    • 在MRI环境中提供心律失常治疗的系统和方法
    • US08639331B2
    • 2014-01-28
    • US12639848
    • 2009-12-16
    • Scott R. StubbsJames O. GilkersonDiane Schuster
    • Scott R. StubbsJames O. GilkersonDiane Schuster
    • A61N1/00
    • A61N1/3931A61N1/3688A61N1/37A61N1/3718
    • Systems and methods for arrhythmia therapy in MRI environments are disclosed. Various systems disclosed utilize ATP therapy rather than ventricular shocks when patients are subjected to electromagnetic fields in an MRI scanner bore and shock therapy is not available. As the patient is moved out from within the scanner bore and away from the MRI scanner, the magnetic fields diminish in strength eventually allowing a high voltage capacitor within the IMD to charge if necessary. The system may detect when the electromagnetic fields no longer interfere with the shock therapy and will transition the IMD back to a normal operational mode where shock therapy can be delivered. Then, if the arrhythmia still exists, the system will carry out all of the system's prescribed operations, including the delivery of electric shocks to treat the arrhythmia.
    • 公开了MRI环境中心律失常治疗的系统和方法。 所公开的各种系统利用ATP治疗而不是心室休克,当患者在MRI扫描器孔中经受电磁场并且不能使用休克疗法时。 当患者从扫描仪孔内移出并远离MRI扫描仪时,磁场的强度减弱,最终允许IMD内的高电压电容器根据需要进行充电。 该系统可以检测何时电磁场不再干扰休克疗法,并将IMD转移回正常的操作模式,其中可以进行休克疗法。 那么,如果心律失常仍然存在,系统将执行系统的所有规定的操作,包括交付电击治疗心律失常。
    • 4. 发明申请
    • SYSTEMS AND METHODS FOR PROVIDING ARRHYTHMIA THERAPY IN MRI ENVIRONMENTS
    • 在MRI环境中提供ARRHYTHMIA治疗的系统和方法
    • US20100211123A1
    • 2010-08-19
    • US12639848
    • 2009-12-16
    • Scott R. StubbsJames O. GilkersonDiane Schuster
    • Scott R. StubbsJames O. GilkersonDiane Schuster
    • A61N1/365A61N1/39
    • A61N1/3931A61N1/3688A61N1/37A61N1/3718
    • Systems and methods for arrhythmia therapy in MRI environments are disclosed. Various systems disclosed utilize ATP therapy rather than ventricular shocks when patients are subjected to electromagnetic fields in an MRI scanner bore and shock therapy is not available. As the patient is moved out from within the scanner bore and away from the MRI scanner, the magnetic fields diminish in strength eventually allowing a high voltage capacitor within the IMD to charge if necessary. The system may detect when the electromagnetic fields no longer interfere with the shock therapy and will transition the IMD back to a normal operational mode where shock therapy can be delivered. Then, if the arrhythmia still exists, the system will carry out all of the system's prescribed operations, including the delivery of electric shocks to treat the arrhythmia.
    • 公开了MRI环境中心律失常治疗的系统和方法。 所公开的各种系统利用ATP治疗而不是心室休克,当患者在MRI扫描器孔中经受电磁场并且不能使用休克疗法时。 当患者从扫描仪孔内移出并远离MRI扫描仪时,磁场的强度减弱,最终允许IMD内的高电压电容器根据需要进行充电。 该系统可以检测何时电磁场不再干扰休克疗法,并将IMD转移回正常的操作模式,其中可以进行休克疗法。 那么,如果心律失常仍然存在,系统将执行系统的所有规定的操作,包括交付电击治疗心律失常。
    • 5. 发明授权
    • Implantable medical device with automatic tachycardia detection and control in MRI environments
    • 在MRI环境中具有自动心动过速检测和控制的植入式医疗设备
    • US08565874B2
    • 2013-10-22
    • US12907517
    • 2010-10-19
    • Scott R. StubbsJames O. GilkersonHiten J. DoshiDiane Schuster
    • Scott R. StubbsJames O. GilkersonHiten J. DoshiDiane Schuster
    • A61N1/08A61B5/05
    • A61N1/3962A61N1/056A61N1/086A61N1/37A61N1/3718
    • An implantable medical device (IMD) includes a lead having one or more sensing electrodes and one or more therapy delivery electrodes, and a sensor configured to detect the presence of static and time-varying scan fields in a magnetic resonance imaging (MRI) environment. A controller, in electrical communication with the lead and the sensor, is configured to process signals related to tachycardia events sensed via the one or more sensing electrodes and to deliver pacing and shock therapy signals via the one or more therapy delivery electrodes. The controller compares the sensed static and time-varying scan fields to static and time-varying scan field thresholds. The controller controls delivery of anti-tachycardia pacing and shock therapy signals as a function of the detected tachycardia events, the comparison of the sensed static scan field to the static scan field threshold, and the comparison of the time-varying scan fields to the time-varying scan field thresholds.
    • 可植入医疗装置(IMD)包括具有一个或多个感测电极和一个或多个治疗递送电极的引线,以及配置成检测磁共振成像(MRI)环境中静态和时变扫描场的存在的传感器。 与引线和传感器电连通的控制器被配置为处理与通过一个或多个感测电极感测的心动过速相关的信号,并且经由一个或多个治疗传递电极输送起搏和休克治疗信号。 控制器将感测到的静态和时变扫描场与静态和时变扫描场阈值进行比较。 控制器控制作为检测到的心动过速事件的函数的抗心动过速起搏和休克治疗信号的传递,感测的静态扫描场与静态扫描场阈值的比较,以及时变扫描场与时间的比较 - 扫描场阈值变化。
    • 6. 发明申请
    • IMPLANTABLE MEDICAL DEVICE WITH AUTOMATIC TACHYCARDIA DETECTION AND CONTROL IN MRI ENVIRONMENTS
    • MRI环境中具有自动TACHYCARDIA检测和控制的可植入医疗器械
    • US20110137359A1
    • 2011-06-09
    • US12907517
    • 2010-10-19
    • Scott R. StubbsJames O. GilkersonHiten J. DoshiDiane Schuster
    • Scott R. StubbsJames O. GilkersonHiten J. DoshiDiane Schuster
    • A61N1/365A61N1/39
    • A61N1/3962A61N1/056A61N1/086A61N1/37A61N1/3718
    • An implantable medical device (IMD) includes a lead having one or more sensing electrodes and one or more therapy delivery electrodes, and a sensor configured to detect the presence of static and time-varying scan fields in a magnetic resonance imaging (MRI) environment. A controller, in electrical communication with the lead and the sensor, is configured to process signals related to tachycardia events sensed via the one or more sensing electrodes and to deliver pacing and shock therapy signals via the one or more therapy delivery electrodes. The controller compares the sensed static and time-varying scan fields to static and time-varying scan field thresholds. The controller controls delivery of anti-tachycardia pacing and shock therapy signals as a function of the detected tachycardia events, the comparison of the sensed static scan field to the static scan field threshold, and the comparison of the time-varying scan fields to the time-varying scan field thresholds.
    • 可植入医疗装置(IMD)包括具有一个或多个感测电极和一个或多个治疗递送电极的引线,以及配置成检测磁共振成像(MRI)环境中静态和时变扫描场的存在的传感器。 与引线和传感器电连通的控制器被配置为处理与通过一个或多个感测电极感测的心动过速相关的信号,并且经由一个或多个治疗传递电极输送起搏和休克治疗信号。 控制器将感测到的静态和时变扫描场与静态和时变扫描场阈值进行比较。 控制器控制作为检测到的心动过速事件的函数的抗心动过速起搏和休克治疗信号的传递,感测的静态扫描场与静态扫描场阈值的比较,以及时变扫描场与时间的比较 - 扫描场阈值变化。
    • 8. 发明授权
    • Apparatus to selectively increase medical device lead inner conductor inductance
    • 用于选择性地增加医疗器件引线内部导体电感的装置
    • US08306630B2
    • 2012-11-06
    • US12905336
    • 2010-10-15
    • Scott R. StubbsJeffrey E. StahmannArthur J. FosterRonald W. Kunkel
    • Scott R. StubbsJeffrey E. StahmannArthur J. FosterRonald W. Kunkel
    • A61N1/05
    • A61N1/056A61N1/086
    • A medical device lead includes an insulative lead body, outer and inner conductive coils, and a flexible core assembly. The outer conductive coil extends through the lead body and is coupled to a first electrode at a distal end of the outer conductive coil. The inner conductive coil extends coaxially with the outer conductive coil, is coupled to a second electrode at a distal end of the inner conductive coil, and includes a central lumen. The flexible core assembly is disposed in the central lumen and is comprised of a material that has a saturation magnetization of at least about 1.5 T and a relative permeability of greater than one. The flexible core assembly includes a positioning interface configured for manipulation of the flexible core assembly such that the flexible core assembly translates through the central lumen during insertion and extraction of the flexible core assembly.
    • 医疗器械引线包括绝缘引线体,外部和内部导电线圈以及柔性芯组件。 外部导电线圈延伸穿过引线体并且在外部导电线圈的远端处耦合到第一电极。 与外部导电线圈同轴地延伸的内部导电线圈耦合到内部导电线圈的远端处的第二电极,并且包括中心腔。 柔性芯组件设置在中心腔中,并且由具有至少约1.5T的饱和磁化强度和大于1的相对磁导率的材料构成。 柔性芯组件包括配置用于操纵柔性芯组件的定位接口,使得柔性芯组件在插入和拔出柔性芯组件期间通过中心腔平移。